DOW JONES23,167.96+487.97 2.15%
S&P 5002,716.61+52.93 1.99%
NASDAQ7,984.43+71.19 0.90%

SunTrust Robinson Humphrey Initiates Coverage On Sutro Biopharma with Buy Rating, Announces $18 Price Target

SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and a $18 price target.

Benzinga · 01/13/2020 13:54

SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and a $18 price target.